A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Boston Scientific's Debt-to-Equity or its related term are showing as below:
BSX'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.06 Med: 0.56 Max: 3.64
Current: 0.54
During the past 13 years, the highest Debt-to-Equity Ratio of Boston Scientific was 3.64. The lowest was 0.06. And the median was 0.56.
BSX's Debt-to-Equity is ranked worse than 74.12% of 684
companies
in the Medical Devices & Instruments industry
Industry Median: 0.20
vs BSX: 0.54
Boston Scientific Debt-to-Equity Historical Data
The historical data trend for Boston Scientific's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Boston Scientific Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Debt-to-Equity
0.80
0.81
0.74
0.62
0.57
Boston Scientific Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Debt-to-Equity
0.59
0.58
0.57
0.58
0.54
Competitive Comparison
For the Medical Devices subindustry, Boston Scientific's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boston Scientific Debt-to-Equity Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Boston Scientific's Debt-to-Equity falls into.
Boston Scientific Debt-to-Equity Calculation
Debt to Equity measures the financial leverage a company has.
Boston Scientific's Debt to Equity Ratio for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Boston Scientific (NYSE:BSX) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Boston Scientific Debt-to-Equity Related Terms
Thank you for viewing the detailed overview of Boston Scientific's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.06(0.14%) Volume: 2,695,419 3:15PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:BSX has been successfully added to your 
